P PRIMESTOCKFINDER.COM

BIO Shares Biome Australia Limited

ASX · ASX
$0.37 +1.39% Prices as of close 2026-10-27

Last in our picks 2026-10-20 — not in the current list; analysis below is from that screen

Commercial microbiome portfolio provides revenue exposure alongside product expansion and distribution growth.

Future value: $0.75 (+94.81%) · 6-12 months · analyst consensus

Signal breakdown

  • ▸Commercial progress and healthcare-sector analyst attention support momentum.
  • ▸Above 50-day MA (+6.41%)
  • ▸Above 200-day MA — long-term uptrend
  • ▸~95% upside to price target

Is BIO a buy right now?

Trend: BIO is trading below the 50-day average (-1.35%), RSI 33 — neutral momentum, with a 3-month return of +32.73%.

Valuation & quality: Biome Australia Limited trades on a trailing P/E of 18.3, forward P/E 15.2, price-to-book 8.90; fundamentals show net margin 15.1%, return on equity 51.3%, revenue growth 20.2% year on year.

Analyst consensus: 1 analysts have a mean 12-month price target of A$0.75 (+105.5% vs the last close; range A$0.75 – A$0.75), consensus rating “none”.

Our screen: STRONG BUY (score 4) — Commercial microbiome portfolio provides revenue exposure alongside product expansion and distribution growth.

Computed from end-of-day data; not personal advice.

12-month price chart

0.46 0.22 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-27 (AUD). Range 0.22 – 0.46.

Monthly returns

Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-19.00%-14.70%-20.70%+13.00%+7.70%+28.60%+11.10%-7.50%

Fundamentals

Market cap
$84.5M
P/E (ttm)
18.3
Forward P/E
15.2
EPS (ttm)
$0.02
Price / book
8.90
Beta
0.96
Net margin
15.1%
ROE
51.3%
Revenue growth
20.2%
Revenue (ttm)
$23.9M
Free cash flow
$318,449
Debt / equity
32%
52-wk range
$0.20 – $0.49
Volume
42,207
Avg volume (3m)
218,591

Analyst price target

Mean target
$0.75
Low
$0.75
High
$0.75
Analysts
1
Consensus
NONE

Technical signals

RSI (14)
33.4
vs 50-day MA
-1.35%
1-mo return
-9.88%
3-mo return
+32.73%
Volume z-score
0.16

About Biome Australia Limited

Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names.

Sector: Consumer Defensive · Industry: Packaged Foods · Australia · Website

Related Biotech picks

CSL.AXCSL LimitedMSB.AXMesoblast LimitedIMR.AXImricor Medical SystemSLD.AXSaluda Medical, Inc.NUZ.AXNeurizon Therapeutics NEU.AXNeuren PharmaceuticalsDXB.AXDimerix LimitedNYR.AXNyrada Inc.

Browse: all ASX stocks · Biotech picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.